TermID |Term |Enrichment |logP |Genes in Term|Target Genes in Term|Fraction of Targets in Term|Total Target Genes|Total Genes|Gene Symbols :---------|:-----------------------------------------------------------------------|:------------------|:----------------|:------------|:-------------------|:--------------------------|:-----------------|:----------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------- SMP0000504|Creatine Deficiency- Guanidinoacetate Methyltransferase Deficiency |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |ARG1,RARS2,ASS1,NOS1,P4HA3,PYCR2,CPS1,OTC,GATM,EPRS,ASL,GOT1,CKB,OAT,ALDH4A1,SLC25A15,GAMT SMP0000505|Hyperornithinemia with Gyrate Atrophy (HOGA) |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |ASL,GOT1,CKB,OAT,ALDH4A1,SLC25A15,GAMT,RARS2,ARG1,ASS1,NOS1,P4HA3,PYCR2,OTC,CPS1,GATM,EPRS SMP0000208|Prolinemia Type II |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |GAMT,SLC25A15,ASL,GOT1,OAT,CKB,ALDH4A1,PYCR2,P4HA3,OTC,CPS1,GATM,EPRS,RARS2,ARG1,NOS1,ASS1 SMP0000020|Arginine and Proline Metabolism |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |ALDH4A1,OAT,CKB,GOT1,ASL,SLC25A15,GAMT,NOS1,ASS1,RARS2,ARG1,EPRS,GATM,OTC,CPS1,PYCR2,P4HA3 SMP0000363|Ornithine Aminotransferase Deficiency (OAT Deficiency) |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |CPS1,OTC,P4HA3,PYCR2,EPRS,GATM,RARS2,ARG1,ASS1,NOS1,SLC25A15,GAMT,GOT1,ASL,ALDH4A1,CKB,OAT SMP0000507|L-Arginine:Glycine Amidinotransferase Deficiency |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |ASL,GOT1,CKB,OAT,ALDH4A1,GAMT,SLC25A15,RARS2,ARG1,ASS1,NOS1,P4HA3,PYCR2,CPS1,OTC,GATM,EPRS SMP0000362|Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency) |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |ALDH4A1,CKB,OAT,GOT1,ASL,GAMT,SLC25A15,ASS1,NOS1,ARG1,RARS2,EPRS,GATM,OTC,CPS1,P4HA3,PYCR2 SMP0000360|Hyperprolinemia Type II |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |GAMT,SLC25A15,OAT,CKB,ALDH4A1,ASL,GOT1,GATM,EPRS,PYCR2,P4HA3,CPS1,OTC,NOS1,ASS1,ARG1,RARS2 SMP0000361|Hyperprolinemia Type I |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |GAMT,SLC25A15,ASL,GOT1,OAT,CKB,ALDH4A1,PYCR2,P4HA3,CPS1,OTC,GATM,EPRS,RARS2,ARG1,NOS1,ASS1 SMP0000506|Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome] |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |SLC25A15,GAMT,ASL,GOT1,CKB,OAT,ALDH4A1,P4HA3,PYCR2,CPS1,OTC,GATM,EPRS,ARG1,RARS2,ASS1,NOS1 SMP0000207|Prolidase Deficiency (PD) |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |OAT,CKB,ALDH4A1,ASL,GOT1,GAMT,SLC25A15,NOS1,ASS1,RARS2,ARG1,GATM,EPRS,PYCR2,P4HA3,CPS1,OTC SMP0000188|Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency) |0.00430316210253866|-5.44840515385322|20 |17 |0.0223097112860892 |762 |1394 |OAT,CKB,ALDH4A1,ASL,GOT1,SLC25A15,GAMT,NOS1,ASS1,ARG1,RARS2,GATM,EPRS,PYCR2,P4HA3,CPS1,OTC SMP0000003|Argininosuccinic Aciduria |0.00443822297392698|-5.41750121374937|13 |12 |0.015748031496063 |762 |1394 |GLS2,ARG1,ASL,ASS1,GPT,SLC25A12,OTC,CPS1,GOT2,SLC25A15,SLC1A4,SLC1A5 SMP0000001|Citrullinemia Type I |0.00443822297392698|-5.41750121374937|13 |12 |0.015748031496063 |762 |1394 |SLC1A5,SLC1A4,SLC25A15,GOT2,SLC25A12,OTC,CPS1,GPT,ASS1,ASL,ARG1,GLS2 SMP0000002|Carbamoyl Phosphate Synthetase Deficiency |0.00443822297392698|-5.41750121374937|13 |12 |0.015748031496063 |762 |1394 |GOT2,SLC25A15,SLC1A4,SLC1A5,CPS1,OTC,SLC25A12,ASS1,GPT,GLS2,ARG1,ASL SMP0000205|Ornithine Transcarbamylase Deficiency (OTC Deficiency) |0.00443822297392698|-5.41750121374937|13 |12 |0.015748031496063 |762 |1394 |CPS1,SLC25A12,OTC,GOT2,SLC1A4,SLC25A15,SLC1A5,ARG1,GLS2,ASL,ASS1,GPT SMP0000357|Argininemia |0.00443822297392698|-5.41750121374937|13 |12 |0.015748031496063 |762 |1394 |ASS1,GPT,ARG1,GLS2,ASL,GOT2,SLC25A15,SLC1A4,SLC1A5,SLC25A12,OTC,CPS1 SMP0000059|Urea Cycle |0.00443822297392698|-5.41750121374937|13 |12 |0.015748031496063 |762 |1394 |CPS1,SLC25A12,OTC,SLC1A5,GOT2,SLC1A4,SLC25A15,ASL,ARG1,GLS2,ASS1,GPT SMP0063807|Growth Hormone Signaling Pathway |0.0242997853015307 |-3.71728776400262|22 |17 |0.0223097112860892 |762 |1394 |GHR,MAPK1,SOS1,SOCS1,GRB2,STAT5A,RPS6KA1,INSR,STAT5B,HNF1A,SRF,SLC2A4,RAF1,JAK2,ORAI1,PRKCA,MAP2K1 SMP0000429|Disulfiram Action Pathway |0.079396584192735 |-2.53329993189708|24 |17 |0.0223097112860892 |762 |1394 |FAH,COMT,HAAO,CAT,GOT1,PNMT,ACSS2,ACSS1,MAOA,HGD,ALDH1B1,DCT,ALDH2,HPD,MIF,TAT,DDC SMP0000099|Lovastatin Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |LIPA,TM7SF2,NSDHL,HMGCR,MVK,DHCR24,MSMO1,GGPS1,FDFT1,IDI1,FDPS,HSD17B7,SOAT1,ACAT2,CYP51A1 SMP0000119|Fluvastatin Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |IDI1,FDPS,HSD17B7,SOAT1,ACAT2,CYP51A1,MVK,DHCR24,MSMO1,FDFT1,GGPS1,NSDHL,HMGCR,LIPA,TM7SF2 SMP0000508|Cholesteryl Ester Storage Disease |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |FDFT1,GGPS1,MSMO1,DHCR24,MVK,ACAT2,CYP51A1,SOAT1,HSD17B7,FDPS,IDI1,TM7SF2,LIPA,HMGCR,NSDHL SMP0000107|Zoledronate Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |NSDHL,HMGCR,LIPA,TM7SF2,FDPS,SOAT1,HSD17B7,IDI1,CYP51A1,ACAT2,DHCR24,MVK,FDFT1,GGPS1,MSMO1 SMP0000117|Pamidronate Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |FDFT1,GGPS1,MSMO1,DHCR24,MVK,ACAT2,CYP51A1,SOAT1,FDPS,HSD17B7,IDI1,TM7SF2,LIPA,HMGCR,NSDHL SMP0000092|Rosuvastatin Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |TM7SF2,LIPA,HMGCR,NSDHL,FDFT1,GGPS1,MSMO1,DHCR24,MVK,CYP51A1,ACAT2,FDPS,HSD17B7,SOAT1,IDI1 SMP0000509|Hyper-IgD Syndrome |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |HMGCR,NSDHL,TM7SF2,LIPA,ACAT2,CYP51A1,IDI1,SOAT1,FDPS,HSD17B7,MSMO1,GGPS1,FDFT1,MVK,DHCR24 SMP0000209|Hypercholesterolemia |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |LIPA,TM7SF2,NSDHL,HMGCR,MVK,DHCR24,MSMO1,FDFT1,GGPS1,IDI1,HSD17B7,SOAT1,FDPS,ACAT2,CYP51A1 SMP0000131|Atorvastatin Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |TM7SF2,LIPA,HMGCR,NSDHL,MSMO1,GGPS1,FDFT1,MVK,DHCR24,CYP51A1,ACAT2,IDI1,FDPS,SOAT1,HSD17B7 SMP0000388|Chondrodysplasia Punctata II- X-Linked Dominant (CDPX2) |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |HMGCR,NSDHL,TM7SF2,LIPA,ACAT2,CYP51A1,IDI1,SOAT1,FDPS,HSD17B7,MSMO1,FDFT1,GGPS1,MVK,DHCR24 SMP0000111|Cerivastatin Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |FDFT1,GGPS1,MSMO1,DHCR24,MVK,ACAT2,CYP51A1,HSD17B7,SOAT1,FDPS,IDI1,TM7SF2,LIPA,HMGCR,NSDHL SMP0000387|CHILD Syndrome |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |CYP51A1,ACAT2,HSD17B7,FDPS,SOAT1,IDI1,GGPS1,FDFT1,MSMO1,DHCR24,MVK,HMGCR,NSDHL,TM7SF2,LIPA SMP0000386|Desmosterolosis |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |DHCR24,MVK,GGPS1,FDFT1,MSMO1,HSD17B7,SOAT1,FDPS,IDI1,CYP51A1,ACAT2,LIPA,TM7SF2,NSDHL,HMGCR SMP0000319|Lysosomal Acid Lipase Deficiency (Wolman Disease) |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |LIPA,TM7SF2,NSDHL,HMGCR,DHCR24,MVK,FDFT1,GGPS1,MSMO1,SOAT1,FDPS,HSD17B7,IDI1,ACAT2,CYP51A1 SMP0000389|Smith-Lemli-Opitz Syndrome (SLOS) |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |NSDHL,HMGCR,LIPA,TM7SF2,HSD17B7,FDPS,SOAT1,IDI1,CYP51A1,ACAT2,DHCR24,MVK,FDFT1,GGPS1,MSMO1 SMP0000082|Simvastatin Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |DHCR24,MVK,FDFT1,GGPS1,MSMO1,HSD17B7,FDPS,SOAT1,IDI1,CYP51A1,ACAT2,LIPA,TM7SF2,NSDHL,HMGCR SMP0000023|Steroid Biosynthesis |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |ACAT2,CYP51A1,HSD17B7,FDPS,SOAT1,IDI1,GGPS1,FDFT1,MSMO1,DHCR24,MVK,HMGCR,NSDHL,TM7SF2,LIPA SMP0000510|Mevalonic Aciduria |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |LIPA,TM7SF2,NSDHL,HMGCR,MVK,DHCR24,MSMO1,FDFT1,GGPS1,IDI1,FDPS,SOAT1,HSD17B7,ACAT2,CYP51A1 SMP0000511|Wolman Disease |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |MSMO1,GGPS1,FDFT1,MVK,DHCR24,CYP51A1,ACAT2,IDI1,HSD17B7,SOAT1,FDPS,TM7SF2,LIPA,HMGCR,NSDHL SMP0000095|Alendronate Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |HMGCR,NSDHL,TM7SF2,LIPA,ACAT2,CYP51A1,IDI1,SOAT1,HSD17B7,FDPS,MSMO1,FDFT1,GGPS1,MVK,DHCR24 SMP0000112|Risedronate Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |TM7SF2,LIPA,HMGCR,NSDHL,GGPS1,FDFT1,MSMO1,DHCR24,MVK,CYP51A1,ACAT2,HSD17B7,FDPS,SOAT1,IDI1 SMP0000089|Pravastatin Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |TM7SF2,LIPA,HMGCR,NSDHL,FDFT1,GGPS1,MSMO1,DHCR24,MVK,ACAT2,CYP51A1,FDPS,HSD17B7,SOAT1,IDI1 SMP0000079|Ibandronate Action Pathway |0.0895284946417105 |-2.41319832848714|21 |15 |0.0196850393700787 |762 |1394 |GGPS1,FDFT1,MSMO1,DHCR24,MVK,ACAT2,CYP51A1,FDPS,HSD17B7,SOAT1,IDI1,TM7SF2,LIPA,HMGCR,NSDHL SMP0000004|Glycine and Serine Metabolism |0.0943142651859478 |-2.36112282627722|26 |18 |0.0236220472440945 |762 |1394 |CTH,GAMT,SHMT2,GARS,GLYCTK,GLDC,ALDH2,ALAS1,DMGDH,PSAT1,PSPH,AGXT,PHGDH,GATM,SARDH,GNMT,MAOA,SARS SMP0000242|Dimethylglycine Dehydrogenase Deficiency |0.0943142651859478 |-2.36112282627722|26 |18 |0.0236220472440945 |762 |1394 |SARS,MAOA,ALDH2,ALAS1,PSPH,PSAT1,DMGDH,PHGDH,AGXT,GNMT,SARDH,GATM,GARS,GLYCTK,GLDC,CTH,GAMT,SHMT2 SMP0000179|Dihydropyrimidine Dehydrogenase Deficiency (DHPD) |0.0943142651859478 |-2.36112282627722|26 |18 |0.0236220472440945 |762 |1394 |GARS,GLDC,GLYCTK,CTH,SHMT2,GAMT,MAOA,SARS,DMGDH,PSPH,PSAT1,ALAS1,ALDH2,GATM,GNMT,SARDH,AGXT,PHGDH SMP0000484|Dimethylglycine Dehydrogenase Deficiency |0.0943142651859478 |-2.36112282627722|26 |18 |0.0236220472440945 |762 |1394 |AGXT,PHGDH,GATM,GNMT,SARDH,ALAS1,ALDH2,DMGDH,PSAT1,PSPH,MAOA,SARS,GAMT,SHMT2,CTH,GLYCTK,GLDC,GARS SMP0000244|Sarcosinemia |0.0943142651859478 |-2.36112282627722|26 |18 |0.0236220472440945 |762 |1394 |AGXT,PHGDH,GATM,SARDH,GNMT,ALDH2,ALAS1,DMGDH,PSPH,PSAT1,MAOA,SARS,GAMT,SHMT2,CTH,GLYCTK,GLDC,GARS SMP0000485|Hyperglycinemia- Non-Ketotic |0.0943142651859478 |-2.36112282627722|26 |18 |0.0236220472440945 |762 |1394 |SARS,MAOA,PSAT1,PSPH,DMGDH,ALAS1,ALDH2,GNMT,SARDH,GATM,PHGDH,AGXT,GARS,GLDC,GLYCTK,CTH,SHMT2,GAMT SMP0000721|3-Phosphoglycerate Dehydrogenase Deficiency |0.0943142651859478 |-2.36112282627722|26 |18 |0.0236220472440945 |762 |1394 |SHMT2,GAMT,CTH,GLDC,GLYCTK,GARS,SARDH,GNMT,GATM,PHGDH,AGXT,PSPH,PSAT1,DMGDH,ALAS1,ALDH2,SARS,MAOA SMP0000223|Non-Ketotic Hyperglycinemia |0.0943142651859478 |-2.36112282627722|26 |18 |0.0236220472440945 |762 |1394 |ALAS1,ALDH2,DMGDH,PSAT1,PSPH,AGXT,PHGDH,GATM,GNMT,SARDH,MAOA,SARS,CTH,GAMT,SHMT2,GARS,GLYCTK,GLDC SMP0063792|TNF/Stress Related Signaling |0.10709461997799 |-2.2340425364224 |23 |16 |0.020997375328084 |762 |1394 |JUN,NFKBIA,TRAF2,TNFRSF1A,ATF1,CRADD,MAP2K7,MAP3K1,MAP2K3,TANK,MAPK14,NFKB1,MAP2K6,RIPK1,MAP4K2,IKBKG SMP0000218|Tyrosinemia Type I |0.13922303640875 |-1.97167805333184|17 |12 |0.015748031496063 |762 |1394 |HGD,HPD,DCT,MIF,TAT,DDC,HAAO,FAH,COMT,MAOA,GOT1,PNMT SMP0000725|Fructose Intolerance- Hereditary |0.13922303640875 |-1.97167805333184|17 |12 |0.015748031496063 |762 |1394 |PFKL,AKR1B1,GMDS,PMM1,ALDOB,KHK,FBP1,ALDOA,SORD,PHPT1,GMPPB,TSTA3 SMP0000169|Alkaptonuria |0.13922303640875 |-1.97167805333184|17 |12 |0.015748031496063 |762 |1394 |HGD,TAT,HPD,DCT,MIF,DDC,FAH,COMT,HAAO,MAOA,GOT1,PNMT SMP0000190|Hawkinsinuria |0.13922303640875 |-1.97167805333184|17 |12 |0.015748031496063 |762 |1394 |TAT,MIF,DCT,HPD,DDC,HGD,GOT1,PNMT,FAH,HAAO,COMT,MAOA SMP0000533|Monoamine Oxidase-A Deficiency (MAO-A) |0.13922303640875 |-1.97167805333184|17 |12 |0.015748031496063 |762 |1394 |HGD,DDC,DCT,MIF,HPD,TAT,MAOA,HAAO,COMT,FAH,PNMT,GOT1 SMP0000561|Fructosuria |0.13922303640875 |-1.97167805333184|17 |12 |0.015748031496063 |762 |1394 |KHK,FBP1,ALDOA,SORD,GMPPB,PHPT1,TSTA3,PFKL,AKR1B1,GMDS,ALDOB,PMM1 SMP0000064|Fructose and Mannose Degradation |0.13922303640875 |-1.97167805333184|17 |12 |0.015748031496063 |762 |1394 |GMPPB,PHPT1,TSTA3,SORD,ALDOA,FBP1,KHK,ALDOB,PMM1,GMDS,AKR1B1,PFKL SMP0000006|Tyrosine Metabolism |0.13922303640875 |-1.97167805333184|17 |12 |0.015748031496063 |762 |1394 |MAOA,HAAO,COMT,FAH,PNMT,GOT1,HGD,DDC,HPD,DCT,MIF,TAT SMP0000498|Dopamine beta-Hydroxylase Deficiency |0.13922303640875 |-1.97167805333184|17 |12 |0.015748031496063 |762 |1394 |MIF,DCT,HPD,TAT,DDC,HGD,GOT1,PNMT,HAAO,FAH,COMT,MAOA SMP0000128|Gluconeogenesis |0.142458342285822 |-1.94870565684792|22 |15 |0.0196850393700787 |762 |1394 |SLC2A2,G6PC,FBP1,ALDOA,GALM,GAPDH,PANK1,PGM1,MPC1,GPI,PCK1,MDH2,SLC37A4,HK2,BPGM SMP0000560|Phosphoenolpyruvate Carboxykinase Deficiency 1 (PEPCK1) |0.142458342285822 |-1.94870565684792|22 |15 |0.0196850393700787 |762 |1394 |FBP1,ALDOA,GALM,GAPDH,SLC2A2,G6PC,GPI,PCK1,BPGM,SLC37A4,MDH2,HK2,PANK1,PGM1,MPC1 SMP0000374|Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease |0.142458342285822 |-1.94870565684792|22 |15 |0.0196850393700787 |762 |1394 |PANK1,PGM1,MPC1,GPI,PCK1,MDH2,HK2,BPGM,SLC37A4,G6PC,SLC2A2,FBP1,ALDOA,GALM,GAPDH SMP0000563|Triosephosphate Isomerase Deficiency |0.142458342285822 |-1.94870565684792|22 |15 |0.0196850393700787 |762 |1394 |GAPDH,GALM,FBP1,ALDOA,SLC2A2,G6PC,MDH2,HK2,SLC37A4,BPGM,PCK1,GPI,MPC1,PGM1,PANK1 SMP0000562|Fructose-1-6-diphosphatase Deficiency |0.142458342285822 |-1.94870565684792|22 |15 |0.0196850393700787 |762 |1394 |HK2,MDH2,SLC37A4,BPGM,PCK1,GPI,MPC1,PGM1,PANK1,GAPDH,GALM,ALDOA,FBP1,G6PC,SLC2A2 SMP0000574|Glycogenosis- Type IC |0.142458342285822 |-1.94870565684792|22 |15 |0.0196850393700787 |762 |1394 |PGM1,PANK1,MPC1,PCK1,GPI,HK2,MDH2,SLC37A4,BPGM,SLC2A2,G6PC,FBP1,ALDOA,GAPDH,GALM SMP0000581|Glycogenosis- Type IA. Von Gierke Disease |0.142458342285822 |-1.94870565684792|22 |15 |0.0196850393700787 |762 |1394 |G6PC,SLC2A2,GAPDH,GALM,FBP1,ALDOA,MPC1,PGM1,PANK1,HK2,MDH2,SLC37A4,BPGM,PCK1,GPI SMP0000573|Glycogenosis- Type IB |0.142458342285822 |-1.94870565684792|22 |15 |0.0196850393700787 |762 |1394 |BPGM,SLC37A4,HK2,MDH2,GPI,PCK1,MPC1,PANK1,PGM1,GALM,GAPDH,FBP1,ALDOA,SLC2A2,G6PC SMP0000063|Tryptophan Metabolism |0.163500220661487 |-1.8109409390342 |19 |13 |0.0170603674540682 |762 |1394 |AFMID,KYNU,ALDH2,ASMT,AOX1,AANAT,DDC,HAAO,CYP1A1,ACMSD,AADAT,CAT,WARS SMP0063811|GnRH Signaling Pathway |0.201759620962418 |-1.60067828542303|47 |29 |0.0380577427821522 |762 |1394 |CAMK2A,PLCB1,CDC42,MMP14,ATF4,MAP2K1,PRKCA,EGR1,MAPK14,RAF1,MMP2,CACNA1D,PLD1,ADCY1,SOS1,HBEGF,GNAS,ITPR1,PTK2B,MAP2K3,MAPK1,SRC,MAP3K1,ACTN4,MAP2K7,GNRH1,PRKACA,GRB2,JUN SMP0031697|Nilotinib Inhibition of BCR-ABL |0.215665611995045 |-1.53402616344703|18 |12 |0.015748031496063 |762 |1394 |GRB2,CRKL,MDM2,CRK,SKP2,MTOR,JAK2,STAT5A,BCL2L1,GAB2,SOS1,PIK3R1 SMP0031694|Imatinib Inhibition of BCR-ABL |0.215665611995045 |-1.53402616344703|18 |12 |0.015748031496063 |762 |1394 |MTOR,JAK2,STAT5A,CRKL,GRB2,MDM2,CRK,SKP2,GAB2,SOS1,PIK3R1,BCL2L1 SMP0031698|Bosutinib Inhibition of BCR-ABL |0.215665611995045 |-1.53402616344703|18 |12 |0.015748031496063 |762 |1394 |BCL2L1,SOS1,PIK3R1,GAB2,SKP2,CRK,MDM2,CRKL,GRB2,STAT5A,MTOR,JAK2 SMP0031699|Bafetinib Inhibition of BCR-ABL |0.215665611995045 |-1.53402616344703|18 |12 |0.015748031496063 |762 |1394 |GAB2,SOS1,PIK3R1,BCL2L1,MTOR,JAK2,STAT5A,CRKL,GRB2,MDM2,SKP2,CRK SMP0031696|Dasatinib Inhibition of BCR-ABL |0.215665611995045 |-1.53402616344703|18 |12 |0.015748031496063 |762 |1394 |SKP2,CRK,CRKL,GRB2,MDM2,STAT5A,JAK2,MTOR,BCL2L1,PIK3R1,SOS1,GAB2 SMP0031700|Ponatinib Inhibition of BCR-ABL |0.215665611995045 |-1.53402616344703|18 |12 |0.015748031496063 |762 |1394 |BCL2L1,GAB2,PIK3R1,SOS1,MDM2,GRB2,CRKL,SKP2,CRK,JAK2,MTOR,STAT5A SMP0000649|Lamivudine Metabolism Pathway |0.215665611995045 |-1.53402616344703|18 |12 |0.015748031496063 |762 |1394 |ABCC4,ABCC1,SULT1A1,PCYT1A,PGK1,ABCC2,SLC22A3,ABCC3,ABCG2,DCK,SLC22A2,CHPT1 SMP0031692|BCR-ABL Action in CML Pathogenesis |0.215665611995045 |-1.53402616344703|18 |12 |0.015748031496063 |762 |1394 |BCL2L1,GAB2,PIK3R1,SOS1,MDM2,CRKL,GRB2,SKP2,CRK,JAK2,MTOR,STAT5A SMP0002292|The Oncogenic Action of Succinate |0.218916977331408 |-1.51906271998515|30 |19 |0.0249343832020997 |762 |1394 |HIF1A,IDH2,SLC25A10,EGLN3,CS,SUCLG1,EGLN2,TET1,SUCLG2,MDH2,ACO1,IDH1,DLST,MPC1,IDH3A,KDM2A,SDHB,OGDH,ACO2 SMP0002295|The Oncogenic Action of Fumarate |0.218916977331408 |-1.51906271998515|30 |19 |0.0249343832020997 |762 |1394 |MPC1,IDH3A,IDH1,DLST,MDH2,ACO1,SUCLG2,ACO2,OGDH,KDM2A,SDHB,SLC25A10,EGLN3,HIF1A,IDH2,TET1,EGLN2,CS,SUCLG1 SMP0000463|Phosphatidylinositol Phosphate Metabolism |0.240732098740309 |-1.42407058728733|20 |13 |0.0170603674540682 |762 |1394 |PIK3C3,AMBRA1,PIKFYVE,PLCB1,VAC14,PIK3R1,ERBB2,PIP5K1A,PI4KA,CDIPT,INPP5D,PIP4K2A,PIK3C2A SMP0064625|CXCR4 Signaling Pathway |0.240732098740309 |-1.42407058728733|20 |13 |0.0170603674540682 |762 |1394 |NFKBIA,GNAI1,CRK,RAF1,MAP2K1,BCAR1,PTK2,PXN,PIK3C2G,CXCR4,PTK2B,MAPK1,NFKB1 SMP0000582|Joubert Syndrome |0.240732098740309 |-1.42407058728733|20 |13 |0.0170603674540682 |762 |1394 |PIK3C2A,PIP4K2A,PIP5K1A,ERBB2,PI4KA,INPP5D,CDIPT,PIK3R1,VAC14,AMBRA1,PIKFYVE,PIK3C3,PLCB1 SMP0000349|Gaucher Disease |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |ACER1,GLB1,SPHK2,NEU3,ENPP7,GBA,ARSA,DEGS2,CERK,ACER3,KDSR,SPTLC2,SGMS1,SGPL1 SMP0000385|Homocarnosinosis |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |GLS2,GSR,GCLC,ABAT,ALDH4A1,GPT,CPS1,GNPNAT1,ALDH5A1,EARS2,GOT2,GFPT1,GSS,GCLM SMP0000339|Hyperinsulinism-Hyperammonemia Syndrome |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |GPT,ALDH4A1,ABAT,GLS2,GCLC,GSR,GCLM,GOT2,GSS,GFPT1,GNPNAT1,ALDH5A1,EARS2,CPS1 SMP0000525|Fabry Disease |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |GLB1,ACER1,SPHK2,NEU3,ENPP7,GBA,ARSA,DEGS2,CERK,SPTLC2,KDSR,ACER3,SGMS1,SGPL1 SMP0000348|Globoid Cell Leukodystrophy |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |DEGS2,SPTLC2,KDSR,ACER3,CERK,SGPL1,SGMS1,GLB1,ACER1,NEU3,SPHK2,GBA,ENPP7,ARSA SMP0000136|2-Hydroxyglutric Aciduria (D and L Form) |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |GSS,GFPT1,GOT2,GCLM,CPS1,EARS2,GNPNAT1,ALDH5A1,ALDH4A1,GPT,GCLC,GSR,GLS2,ABAT SMP0000347|Metachromatic Leukodystrophy (MLD) |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |SPTLC2,KDSR,ACER3,CERK,DEGS2,SGPL1,SGMS1,NEU3,SPHK2,ACER1,GLB1,ARSA,GBA,ENPP7 SMP0000526|Krabbe Disease |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |ENPP7,GBA,ARSA,ACER1,GLB1,SPHK2,NEU3,SGMS1,SGPL1,DEGS2,CERK,ACER3,KDSR,SPTLC2 SMP0000072|Glutamate Metabolism |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |GSS,GFPT1,GOT2,GCLM,CPS1,EARS2,ALDH5A1,GNPNAT1,ALDH4A1,GPT,GCLC,GSR,GLS2,ABAT SMP0000034|Sphingolipid Metabolism |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |GLB1,ACER1,SPHK2,NEU3,ENPP7,GBA,ARSA,DEGS2,CERK,SPTLC2,ACER3,KDSR,SGMS1,SGPL1 SMP0000567|Succinic Semialdehyde Dehydrogenase Deficiency |0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |ALDH4A1,GPT,GLS2,GSR,GCLC,ABAT,GOT2,GSS,GFPT1,GCLM,CPS1,ALDH5A1,GNPNAT1,EARS2 SMP0000243|4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency|0.26408023485041 |-1.3315023021222 |22 |14 |0.0183727034120735 |762 |1394 |ABAT,GCLC,GSR,GLS2,GPT,ALDH4A1,EARS2,GNPNAT1,ALDH5A1,CPS1,GCLM,GSS,GFPT1,GOT2